TARGETING NAD+ TO TREAT CHEMOTHERAPY AND RADIOTHERAPY INDUCED COGNITIVE IMPAIRMENT… Application WO-2016176437-A1 World Intellectual Property Organisation (WIPO) 03 Nov 2016